284 related articles for article (PubMed ID: 26931396)
1. Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc.
Yu C; Niu X; Jin F; Liu Z; Jin C; Lai L
Sci Rep; 2016 Mar; 6():22298. PubMed ID: 26931396
[TBL] [Abstract][Full Text] [Related]
2. The Disordered MAX N-terminus Modulates DNA Binding of the Transcription Factor MYC:MAX.
Schütz S; Bergsdorf C; Goretzki B; Lingel A; Renatus M; Gossert AD; Jahnke W
J Mol Biol; 2022 Nov; 434(22):167833. PubMed ID: 36174765
[TBL] [Abstract][Full Text] [Related]
3. Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein.
Beaulieu ME; Castillo F; Soucek L
Cells; 2020 Apr; 9(4):. PubMed ID: 32331235
[TBL] [Abstract][Full Text] [Related]
4. Myc phosphorylation in its basic helix-loop-helix region destabilizes transient α-helical structures, disrupting Max and DNA binding.
Macek P; Cliff MJ; Embrey KJ; Holdgate GA; Nissink JWM; Panova S; Waltho JP; Davies RA
J Biol Chem; 2018 Jun; 293(24):9301-9310. PubMed ID: 29695509
[TBL] [Abstract][Full Text] [Related]
5. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
[TBL] [Abstract][Full Text] [Related]
6. Ligand clouds around protein clouds: a scenario of ligand binding with intrinsically disordered proteins.
Jin F; Yu C; Lai L; Liu Z
PLoS Comput Biol; 2013; 9(10):e1003249. PubMed ID: 24098099
[TBL] [Abstract][Full Text] [Related]
7. Visualizing single-molecule conformational transition and binding dynamics of intrinsically disordered proteins.
Liu W; Chen L; Yin D; Yang Z; Feng J; Sun Q; Lai L; Guo X
Nat Commun; 2023 Aug; 14(1):5203. PubMed ID: 37626077
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.
Jung KY; Wang H; Teriete P; Yap JL; Chen L; Lanning ME; Hu A; Lambert LJ; Holien T; Sundan A; Cosford ND; Prochownik EV; Fletcher S
J Med Chem; 2015 Apr; 58(7):3002-24. PubMed ID: 25734936
[TBL] [Abstract][Full Text] [Related]
9.
Somlyay M; Ledolter K; Kitzler M; Sandford G; Cobb SL; Konrat R
Chembiochem; 2020 Mar; 21(5):696-701. PubMed ID: 31529763
[TBL] [Abstract][Full Text] [Related]
10. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.
Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P
J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550
[TBL] [Abstract][Full Text] [Related]
11. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
[TBL] [Abstract][Full Text] [Related]
12. Occupancies in the DNA-Binding Pathways of Intrinsically Disordered Helix-Loop-Helix Leucine-Zipper Proteins.
Vancraenenbroeck R; Hofmann H
J Phys Chem B; 2018 Dec; 122(49):11460-11467. PubMed ID: 30184429
[TBL] [Abstract][Full Text] [Related]
13. Mapping Hidden Residual Structure within the Myc bHLH-LZ Domain Using Chemical Denaturant Titration.
Panova S; Cliff MJ; Macek P; Blackledge M; Jensen MR; Nissink JWM; Embrey KJ; Davies R; Waltho JP
Structure; 2019 Oct; 27(10):1537-1546.e4. PubMed ID: 31402220
[TBL] [Abstract][Full Text] [Related]
14. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
Davis LJ; Halazonetis TD
Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
16. Calcium-dependent binding of Myc to calmodulin.
Raffeiner P; Schraffl A; Schwarz T; Röck R; Ledolter K; Hartl M; Konrat R; Stefan E; Bister K
Oncotarget; 2017 Jan; 8(2):3327-3343. PubMed ID: 27926480
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Computational Protocols Addressing Intrinsically Disordered Proteins.
Bhattacharya S; Lin X
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30979035
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of small-molecule binding to intrinsically disordered proteins.
Cuchillo R; Michel J
Biochem Soc Trans; 2012 Oct; 40(5):1004-8. PubMed ID: 22988855
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule modulators of c-Myc/Max and Max/Max interactions.
Berg T
Curr Top Microbiol Immunol; 2011; 348():139-49. PubMed ID: 20680803
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
